VIDEO ACCESS


RELEASE:  August 12, 2020
EXPIRATION:  December 31, 2021 (Credit is not available after this expiration date.)

LEARNING OBJECTIVES:

  • Associate basic platforms and the differences in COVID-19 vaccines being developed
  • Assess issues of vaccine safety and allocation in regards to COVID-19 vaccines
  • Identify the types of immune responses that occur after SARS-CoV-2 infection
  • Explain the kinetics of the immune response to SARS-CoV-2 infection


ACCREDITATION STATEMENT

https://ce.mayo.edu/sites/default/files/CPD-JointAccreditationLogo%20%282%29_0.png

 

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

CREDIT STATEMENT(S)

AMA
The  Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS

  • Click the Start button below
  • Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes have between 2-5 questions.
  • Complete the evaluation and click through to the end to ensure credits post to your transcript.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation Interprofessional Continuing Education,  Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities.  Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclosure all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclosure any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants may formulate their own judgments regarding the presentation.

Listed below are the individuals with control of the content of this program who have disclosed.

Relevant financial relationship(s) with industry:
Dr. Aaron Mansfield                           Honoraria                          Genentech Advisory Board, AbbieVie Advisory Board
                                                          Grant/Research Support    Verily, Novartis
Dr. Mary Jo Kasten,  M.D.                 Shareholder                       Pfizer, Aetna, Mylan, Baxter, Medtronic, 3M, Bristol Myer, Cigna, Lily, Excel, Allergan, PTC Therapeutics

Speaker:
Gregory A. Poland, M.D.
Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative advice on vaccine development to Merck & Co., Medicago, GlaxoSmithKline, Sanofi Pasteur, Emergent Biosolutions, Dynavax, Genentech, Eli Lilly and Company, Janssen Global Services LLC, Kentucky Bioprocessing, and Genevant Sciences, Inc. Dr. Poland holds patents related to vaccinia, influenza, and measles peptide vaccines. Dr. Poland has received grant funding from ICW Ventures for preclinical studies on a peptide-based COVI D-19 vaccine. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. 

No relevant financial relationship(s) with industry:
Ms. RaeAnne Boldt
Dr. John Bundrick
Dr. Meltiady Issa
Ms. Jeanine Kiefer
Dr. Darlene Nelson
Dr. Amy Oxentenko
Dr. Vijay Shah
Dr. Karna Sundsted
Dr. Colin West
Dr. Amy Williams
Ms. Deanna Wolf

Speaker:

Richard B. Kennedy, Ph.D.
Co-Director of Vaccine Research Group, Division of General Internal Medicine

Off Label/Investigational Usage: 
All treatments for COVID are off label at the present time.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
MAYO STAFF: 
Contact RaeAnne Boldt at 3-1846
MAYO CLINIC CARE NETWORK MEMBERS: Contact cme@mayo.edu

SUPPORT LOCATION:
Minnesota

Presenter: 
Gregory A. Poland, M.D.
Co-presenter: 
Richard B. Kennedy, Ph.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota